# Dexcom

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/dexcom
Canonical HTML page: https://getyourbrief.com/entity/dexcom

## Recent coverage (2 stories, network-wide)

### Benchmark Raises Price Targets: INBK +6% to $35, DXCM +6.5% to $82
2026-08-12 13:01:32 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Benchmark boosted outlooks on two disparate stocks—First Internet Bancorp and DexCom—offering a stark contrast in risk/reward. While INBK promises 21.74% upside based on the new $35 target, DXCM’s $82 target sits slightly below its trading price, highlighting valuation concerns despite a Buy rating.
Full story: https://getfinancebrief.com/story/benchmark-raises-inbk-dxcm-july-2026

### Medtronic’s MiniMed Prices $560 Million IPO at $20 Per Share
2026-03-06 03:37:58 · Sector: finance · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Medtronic plc has priced the initial public offering of its diabetes-focused subsidiary, MiniMed Group Inc., at $20.00 per share for 28 million shares. The $560 million carve-out aims to provide the specialized unit with independent capital to compete in the high-growth insulin delivery and monitoring market.
Full story: https://getfinancebrief.com/story/medtronic-minimed-ipo-pricing-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.